It rose $2.64, placing it 25th among the top 50 biggest swings in Wall Street during the time frame.
Shares in Kezar Life Sciences Inc. finished on June 29 at $7.93.
Kezar Life Sciences Inc. employs 56 people and has reported -$57,660,000 USD in income.
Stock fluctuations are affected by several factors, from news about the company involved to global trade difficulties or successes.
Despite a tumultuous year with the COVID-19 pandemic, the US stock market overall remained strong in 2021.
Tony Despirito at investment firm BlackRock said “Overall, companies have beat analyst expectations on both earnings per share and revenue growth. But the latter has been particularly strong.”
Nothing in this article is to be assumed as financial advice.
Top 50 biggest stock market swings on June 29
| Company Name | Percentage Change | Current Trading Price |
|---|---|---|
| Exicure Inc. | 2,187.4% | $2.77 |
| Minerva Neurosciences Inc. | 765.6% | $3.42 |
| Regulus Therapeutics Inc. | 624.1% | $2.1 |
| Staffing 360 Solutions Inc. | 614.3% | $5.5 |
| Everything Blockchain Inc. | 128.9% | $4.35 |
| USA Truck Inc. | 122.4% | $31.4 |
| Epizyme Inc. | 113.6% | $1.47 |
| Rain Therapeutics Inc. | 112.9% | $4.94 |
| Ocean Bio-Chem Inc. | 111% | $12.87 |
| Guskin Gold Corp. | 98.4% | $2.5 |
| Femasys Inc. | 93% | $2.76 |
| Fortinet Inc. | -78.7% | $57.17 |
| Splash Beverage Group Inc. | 71.7% | $3.09 |
| Decibel Therapeutics Inc. | 66.1% | $3.82 |
| Toughbuilt Industries Inc. | 63.5% | $2.42 |
| Mosaic Immunoengineering Inc. | 60.7% | $1.8 |
| Omega Therapeutics Inc. | 54.9% | $4.26 |
| Tyra Biosciences Inc. | 54.6% | $8.13 |
| Ecoark Holdings Inc. | 54.5% | $2.75 |
| Lexicon Pharmaceuticals Inc. | 53.4% | $2.24 |
| TRACON Pharmaceuticals Inc. | 51.9% | $2.02 |
| Entrada Therapeutics Inc. | 51.2% | $12.94 |
| Boxed Inc. | 50.8% | $1.96 |
| Benitec Biopharma Inc. | 50% | $1.35 |
| Kezar Life Sciences Inc. | 49.9% | $7.93 |
| 4 Less Group Inc. | 49.6% | $7.9 |
| SolarWindow Technologies Inc. | 48.6% | $2.6 |
| Biotricity Inc. | 47.9% | $1.73 |
| Heliogen Inc. | -45.4% | $1.97 |
| Clovis Oncology Inc. | 44.9% | $1.71 |
| Cymabay Therapeutics Inc. | 44.7% | $2.85 |
| 908 Devices Inc. | 44.1% | $20.38 |
| Castle Biosciences Inc. | 43.8% | $23.01 |
| Redbox Entertainment Inc. | -43.5% | $6.79 |
| Aspen Aerogels Inc. | -42.7% | $8.43 |
| Sera Prognostics Inc. | 42.5% | $1.81 |
| Nutriband Inc. | 42.2% | $4.21 |
| PTC Therapeutics Inc. | 42.2% | $40.4 |
| Monte Rosa Therapeutics Inc. | 42.1% | $9.79 |
| Aeye Inc. | -40.9% | $1.76 |
| Terawulf Inc. | -40.9% | $1.23 |
| Sidus Space Inc. | -40.6% | $3.66 |
| Frequency Therapeutics Inc. | 40.4% | $1.53 |
| Clearpoint Neuro Inc. | 40% | $13.65 |
| Science 37 Holdings Inc. | -39.3% | $1.98 |
| Nuvalent Inc. | 39.2% | $13.95 |
| Pardes Biosciences Inc. | -38.3% | $3.01 |
| Satsuma Pharmaceuticals Inc. | 38.3% | $4.01 |
| M&F Bancorp Inc. | 38.1% | $10 |
| Hyperfine Inc. | 37.1% | $2.7 |
Alerts Sign-up